CardioComm Solutions Confirms Therapeutics Goods Administration Clearance for the Sale of GEMS(TM) WIN in Australia

Oct 28, 2014 (Newsfile Corp via COMTEX)  CardioComm Solutions, Inc. (TSXV: EKG) ( CardioComm Solutions or the Company ), a global medical provider of electrocardiogram ( ECG ) acquisition and management software solutions, today announced that is has signed an agency agreement with Cardiac Innovations Australia Pty. Ltd. ( Cardiac Innovations ), a distributor of medical hardware and software solutions into local hospitals and clinics in Australia. CardioComm Solutions acknowledged the Cardiac Innovations relationship once it was confirmed this distributor had successfully obtained an Australian Register of Therapeutic Goods Certificate from the Department of Health, Therapeutics Goods Administration ( TGA ). TGA clearance is the required regulatory approval for the sale of any of CardioComm Solutions products into the Australian medical market. The agreement with Cardiac Innovations also makes provision for the future sale of other CardioComm Solutions products and solutions with add
http://bit.ly/1FTgDCu